Benchmark analysis of three recombinant expression platforms for engineering phage lysins against Limosilactobacillus fermentum
Year: 2026
Type: article
Abstract: Modular engineering of phage lysins is a common approach to obtain application-ready antimicrobial enzymes. This is sometimes coupled with the construction of combinatorial libraries of thousands of variants that are expressed in a heterologous host, most usually Escherichia coli , and then screened for activity against the target bacteria and experimental conditions. While this approach has yielded in the past valuable lysin-based antimicrobials, the impact of the selected expression host has rarely been investigated. We systematically compared three heterologous expression workflows in three different hosts: Saccharomyces cerevisiae , Pichia pastoris , and E. coli , for lysin expression and screening. By creating compatible expression vectors, we coupled the DNA assembly technique VersaTile for lysin diversity generation with two modes of expression in yeasts: surface display and secretion in S. cerevisiae and secretion in P. pastoris . A case study of evaluating lysin variants acting against the bioethanol fermentation contaminant Limosilactobacillus fermentum was used to compare the yeast systems and the canonical E. coli intracellular expression. Our results revealed significant differences in both the number and type of hits identified across the expression platforms: S. cerevisiae resulted in higher diversity, while screening in E. coli appeared most stringent. Several new lysins were identified, across the three expression systems, with strong activity against L. fermentum , even under ethanol-rich conditions mimicking bioethanol fermentation tanks. Our findings highlight the influence of the expression format on the screening outcomes, demonstrating the principle: “you get what you screen for”, and establishing a versatile platform for the development of next-generation antimicrobials against industrial contaminants.
Language: English
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,890
OpenAlex ID: W7236599411
